Evidence map›Paper›PMID 42052088›Full record

SynthesisFrontiers in cellular and infection microbiology2026

The clinical and epidemiological landscape of

Hassan Almarhabi, Abdulmajeed Sarhan, Abdulellah Almohaya, Aisha Alharbi

Abstract readSystematic Review
In one paragraph

Synthesis in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Hassan AlmarhabiDepartment of Medicine, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Jeddah, Saudi Arabia.
Abdulmajeed SarhanKing Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia.
Abdulellah AlmohayaDepartment of Medicine, Ministry of National Guard - Health Affairs, Riyadh, Saudi Arabia.
Aisha AlharbiKing Abdullah International Medical Research Centre, Jeddah, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Methods: To identify the epidemiology, risk factors, presentations, and antimicrobial susceptibility of Results: We identified 22 studies reporting on 69 cases of Conclusion: This review identified a significant variability in the diagnosis and treatment of Systematic review registration: https://www.crd.york.ac.uk/prospero/, identifier CRD420250653025.

Indexed as

Mycobacterium Infections, NontuberculousNontuberculous MycobacteriaAdultAntitubercular AgentsDrug Resistance, BacterialFemaleHumansMaleMicrobial Sensitivity TestsRisk FactorsAntitubercular Agentsantimicrobial sensitivity testsclinical presentationsMycobacterium riyadhenseoutcomerisk factorssystematic reviewtreatment

Identifiers

PMID42052088
PMCPMC13111270

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.